Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DD… Read more
Creative Medical Technology Holdings Inc (CELZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.209x
Based on the latest financial reports, Creative Medical Technology Holdings Inc (CELZ) has a cash flow conversion efficiency ratio of -0.209x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.17 Million) by net assets ($5.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Creative Medical Technology Holdings Inc - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Creative Medical Technology Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Creative Medical Technology Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Creative Medical Technology Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hemogenyx Pharmaceuticals Plc
PINK:HOPHF
|
6.924x |
|
High Sierra Technologies Inc
PINK:HSTI
|
0.043x |
|
Vastland Indonesia
JK:VAST
|
0.092x |
|
Humpuss Intermoda Transportasi
JK:HITS
|
0.053x |
|
CHRISTIAN DIOR - Dusseldorf Stock Exchang
DU:DIO
|
N/A |
|
Bakhu Holdings Corp
PINK:BKUH
|
0.044x |
|
Photon Energy N.V.
WAR:PEN
|
0.119x |
|
Red Sky Energy Ltd
AU:ROG
|
0.032x |
Annual Cash Flow Conversion Efficiency for Creative Medical Technology Holdings Inc (2006–2024)
The table below shows the annual cash flow conversion efficiency of Creative Medical Technology Holdings Inc from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.34 Million | $-5.30 Million | -0.836x | -7.71% |
| 2023-12-31 | $10.34 Million | $-8.03 Million | -0.776x | -57.92% |
| 2022-12-31 | $15.86 Million | $-7.80 Million | -0.491x | -126.63% |
| 2021-12-31 | $10.22 Million | $-2.22 Million | -0.217x | -2086.29% |
| 2020-12-31 | $-39.80 Million | $-434.56K | 0.011x | -92.74% |
| 2019-12-31 | $-8.07 Million | $-1.21 Million | 0.150x | -42.95% |
| 2018-12-31 | $-3.99 Million | $-1.05 Million | 0.263x | -33.79% |
| 2017-12-31 | $-2.24 Million | $-889.62K | 0.398x | -85.90% |
| 2016-12-31 | $-157.79K | $-445.23K | 2.822x | +3443.05% |
| 2015-12-31 | $-183.80K | $-14.64K | 0.080x | -29.63% |
| 2014-12-31 | $-153.04K | $-17.32K | 0.113x | -38.23% |
| 2013-12-31 | $-125.03K | $-22.91K | 0.183x | +6.76% |
| 2012-12-31 | $-97.75K | $-16.77K | 0.172x | -11.29% |
| 2011-12-31 | $-72.16K | $-13.96K | 0.193x | -31.88% |
| 2010-12-31 | $-48.11K | $-13.66K | 0.284x | -71.50% |
| 2009-12-31 | $-30.85K | $-30.74K | 0.996x | +101.32% |
| 2008-12-31 | $757.00 | $-57.16K | -75.514x | -15375.15% |
| 2007-12-31 | $26.35K | $-12.86K | -0.488x | -995.05% |
| 2006-12-31 | $20.89K | $1.14K | 0.055x | -- |